|
Vol. 34 Nº 8 |
Lat. Am. J. Pharm. 34 (8): 1485-1696 (2015) |
REGULAR ARTICLES |
|
|
Development and Validation of a Method for the Analysis of Vancomycin in Human Serum Using Ultracentrifuge Protein Precipitation and UV Spectroscopy *
TARIQ M.H., NAUREEN H., ABBAS N. & AKHLAQ M. (1489)
|
|
|
|
Pharmacobotanical Study of the Leaves and Stems of Baccharis ochracea Spreng. for Quality Control *
BARRETO I.F., PADILHA DE PAULA J., FARAGO P.V., DUARTE M.R. & BUDEL J.M. (1497)
|
|
|
|
Development and Validation of a Stability-indicating RP-HPLC Method for the Determination of Rivaroxaban in Pharmaceutical Formulations *
WALTER M.E., PEROBELLI R.F., da SILVA F.S., CARDOSO JÚNIOR C.D.A., da SILVA I.S. & DALMORA S.L. (1503)
|
|
|
|
Synthesis, Spectral Characterization and Biological Activities of Methyl Substituted Amino Acid Conjugated Sulfonamides *
QADIR M.A., AHMED M., SHAFIQ M.I., MAHMOOD N., ANWAR S., HABIB T., & NOSHEEN S. (1511)
|
|
|
|
Development of Generic Gliclazide 60 mg Modified Release Tablets Using Central Composite Design *
ELSAYED T.M., MANDAL U.K. & KASMURI A. (1516)
|
|
|
|
Subacute Toxicity Study of Lacidipine Nanoformulation *
SHIRODKAR R., REDDY N., KUMAR N., RAMALINGAYYA G., MUTALIK S. & LEWIS S. (1526)
|
|
|
|
Liquid Chromatography Mass Spectrometry for the Determination of ZLJ-601 in Dog Plasma and its Application to Pharmacokinetic Study *
ZHANG L., SONG X., WANG N., XIE X., YUAN L. & GAO M. (1534)
|
|
|
|
Comparison of HPLC-MS/MS and Enzyme-multiplied Immunoassay in Tacrolimus Determination and its Application in Therapeutic Drug Monitoring *
LI W., YUAN G., LIU H., SHAIKH A.S., KONG X., WANG Y. & GUO R. (1540)
|
|
|
|
Determination and Pharmacokinetic Study of Caudatin in Rat Plasma by UPLC *
LI X., LI J., WEI J., SHAN Y., HU Y. & LIN J. (1547)
|
|
|
|
One Dose of Basiliximab in the Prevention of Acute Rejection in Renal Transplant Recipients *
TIAN C., ZHANG X., LIU S., YAN J. & WANG H. (1553)
|
|
|
|
Determination of Ivabradine and its Main Metabolite in Rat Plasma by UPLC-MS/MS and its Application to Pharmacokinetics *
SUN W., HUANG C., WANG Z., LIAN Q., HU G., WANG Z. & CHEN H. (1558)
|
|
|
|
Simultaneous Determination of Imatinib and its Active Metabolite by UPLC-MS/MS in Rat Plasma and its Application to a Pharmacokinetic Study *
ZHANG K., GUO H., ZHANG X., ZHOU M. & CHANG Z. (1565)
|
|
|
|
Dissolution Thermodynamics and Solubility of Atenolol in Seven Different Solvents Useful in Dosage Form Design *
ANWER M.K. (1571)
|
|
|
|
Simultaneous Determination of Lapatinib, Cabozantinib, Imatinib, Dasatinib, Sorafenib, Crizotinib, Erlotinib and SAHA in Rat Plasma by UPLC-MS/MS *
WANG J., ZHOU Y., WANG C., & CHEN J. (1576)
|
|
|
|
Formulation and Characterization of Mucoadhesive Buccal Films of Trimetazidine Dihydrochloride *
IIZHAR S.A., AHMED A.M. & ARIEF M. (1585)
|
|
|
|
Antibacterial Activity of Newly Synthesized 5-Hydrazono-triazoloquinazolines *
AL-SALAHI R., RABAB E.D. & MOHAMED M. (1594)
|
|
|
|
Pharmaceutical Equivalence of Anti-Hypertensive Tablets Distributed by a Brazilian Governmental Program *
LOCATELLI T., DA SILVA A.K. & SAUSEN T.R. (1601)
|
|
|
|
Development and Validation of a Stability-Indicating RP-HPLC and UV Spectrophotometric Methods for the Estimation of Fluindione in Bulk and Tablet Dosage Form *
MALLIKARJUNA RAO N. & GOWRISANKAR D. (1607)
|
|
|
|
Prediction of Drug Solubility Data in Polyethylene Glycols + Water Mixtures at Various Temperatures *
KERAMATNIA F., SHAYANFAR A., BOZORGI A.H., MOTTAGHI M. & JOUYBAN A. (1614)
|
|
|
|
Cerebrovascular Disease Treatment Drug Schisandrin B Affects the Complete Metabolic Profile of Anti-Glioma Drug Noscapine *
LIU Z., LIU Y., ZHOU H., FU X. & HU G. (1622)
|
|
|
|
Development and Evaluation of Nasal Gel Formulations of Chlorpheniramine Maleate *
SHERI P.S. & PRASANTH V.V. (1629)
|
|
|
|
Formulation, Development and Optimization of Propranolol Mucoadhesive Bilayer Tablets by Using Central Composite Design and its In Vitro Studies *
MASSUD A., ISHFAQ B., AHMED B. & QADIR M.I. (1637)
|
|
|
|
Biophysical Study on the Interaction of Ropivacaine with Human Serum Albumin Using Spectroscopic Methods *
WANG K., YAO J., LI Z., ZHU Y., SHAO W. & YU L. (1645)
|
|
|
|
Citronellol Terpenoid Inhibits Cancer Cell Proliferation and Induces Apoptosis in Non-Small Cell Lung Carcinoma *
SONG W., LIU X. & SHI Y. (1652)
|
|
|
|
Determination of Fluoride by Using Ion Selective Electrode (ISE) Method in Urine of Healthy Volunteer and Patients Before-After Sevoflurane Anesthesia *
KADIOGLU Y., GULABOGLU M., OZTURK M. & DOGAN N. (1658)
|
|
|
|
Coagel from L-Ascorbyl Ibuprofenate: Properties, Characterization and Application *
WAN Q. & TANG L. (1664)
|
|
|
SHORT COMMUNICATIONS |
|
|
The regulating inotropic activity of 6-substituted-oxy-[1,2,4]triazolo[3,4-a]phthalazine *
WEI C., CAO Q., GONG G., JIN Q. & QUAN Z. (1672)
|
|
|
|
Metabolomics to Analyze the Therapy and Adverse Effect of Glycyrrhizin Capsules Towards Liver Cancer *
YANG R., ZHANG F., SUN S., LIN L., LUAN Q. & WU Y. (1677)
|
|
|
|
Albumin Affects the Inhibition of UDP-Glucuronosyltransferase (UGT) 2B7 by Cervical Carcinoma Treatment Drug Andrographolide *
LI L., CUI W., HUANG C. & ZHAO L. (1680)
|
|
|
|
Etidronate Loaded Gelatin Nanoparticles by Nanoprecipitation *
RANGABHATLA A., TANTISHAIYAKUL V. & OUNGBHO K. (1684)
|
|
|
|
Drug-Drug Interaction between Anaesthetic Drug Propofol and Andrographolide Derivative *
LI M., PAN W., WANG G., Zhi LI Z., MA J., LI K. & SHI C. (1688)
|
|
|
|
Influence of Drug-Metabolizing Enzymes by Autism Treatment Drug Haloperidol *
LIN X., WANG Z. & FENG W. (1693)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|